- Genetic counseling and evaluation of patients and families affected with a genetic/ inherited disease.
- Genetic tests for diagnosis, predictive testing, screening and prenatal diagnosis of common genetic disorders (1000 tests including cytogenetic, molecular genetic, next-gen-sequencing, whole exome sequencing and chromosomal microarray)
- Basic, applied and translational research in human and medical genetics
- Teaching/ training undergraduate/ post graduate students in genetic techniques and guiding them in short research projects
Genetic Testing Services
Various genetic tests are available at the Department of Genetics at KFRC/ KIMS. Please find below a list for the same. The Genetic Department has collaborations with some specialized genetic testing laboratories for tests such as microarray analysis (for detection of small deletions and duplications), next-gen sequencing of multiple-gene panels (for various genetic conditions) and also caters to whole exome/ genome analysis in families with rare syndromes and difficult-to-diagnose conditions.
Hence, if you as a clinician or patient or family member are interested in a certain test that is not in the list below, feel free to contact out Chief geneticist, Dr. Pavani Upendram. For details about the turn-around-time, cost of test and discussion of cases, kindly call 040-44885053/ 5078/ 5166.
DNA isolation and banking
S.No | Name of Service | Sample Requirement |
1 | From Blood sample - For patients likely to require molecular genetic testing, parents and siblings of probands, critically ill babies/ children with birth defects | 4 ml Peripheral blood (EDTA) |
2 | From Fetal tissue/ Abortus material - For recurrent pregnancy losses/ congenital malformations/ stillborn baby | 20 mg/ml POC in saline/phosphate buffer saline |
Genetic test-based prediction of drug response and adverse effects
S.no | Sample Requirement | Sample Requirement |
1 | Clopidogrel response Genotyping – 3 variants (CYP2C19, ABCB1) - For the genetic prediction of antiplatelet resistance and the estimated tendency for ischemic or thrombotic events/ bleeding adverse reactions | 4 ml Peripheral blood (EDTA) |
2 | Clopidogrel response Genotyping – 6 variants (CYP2C19, ABCB1) - For the genetic prediction of antiplatelet resistance and the estimated tendency for ischemic or thrombotic events/ bleeding adverse reactions | 4 ml Peripheral blood (EDTA) |
3 | Tacrolimus sensitivity genotyping - ABCB1 three variants - For predicting drug response to Tacrolimus (an immunosuppressive drug used in transplant patients) | 4 ml Peripheral blood (EDTA) |
4 | Warfarin/ Acenocoumarol Genotyping - Prediction of bleeding risk (F5, CYP2C9, VKORC1 variants, age factor) - For predicting bleeding risk in users of oral anticoagulants | 4 ml Peripheral blood (EDTA) |
5 | Statin drug response Genotyping (CYP3A4, SLCO1B1) - Prediction of statin therapeutic dose and risk of statin-induced myopathy | 4 ml Peripheral blood (EDTA) |
Single-gene Mendelian disorders
S.no | Sample Requirement | Sample Requirement | |
1 | Noonan syndrome –
| 4 ml Peripheral blood (EDTA) | |
2 | Factor V Leiden mutation- For recurrent abortions and thrombosis predisposition | 4 ml Peripheral blood (EDTA) | |
3 | Factor II 20210 mutation -Prothrombin - For recurrent abortions and thrombophilia predisposition | 4 ml Peripheral blood (EDTA) | |
4 | Cystic Fibrosis -
| 4 ml Peripheral blood (EDTA) | |
5 | APOE genotyping – Three isoforms E2, E3, E4 - For risk of Alzheimer's disease/ Dementia and Type III hyperlipidemia | 4 ml Peripheral blood (EDTA) | |
6 | Thalassemia screening (HBB - 5 common mutations) - For diagnosis and carrier testing of Beta Thalassemia | 4 ml Peripheral blood (EDTA) | |
7 | Cardiovascular disease risk – (MYBPC3 variant)- For diagnosis and predictive testing of cardiovascular disease among Indians | 4 ml Peripheral blood (EDTA) |
Customized molecular genetic testing
S.no | Sample Requirement | Sample Requirement |
1 | Targeted mutation analysis - Targeted mutation analysis or Single exon analysis for any known gene | 4 ml Peripheral blood (EDTA) |
2 | Whole gene sequencing of any known disease-gene-
| 4 ml Peripheral blood (EDTA) |
Next-Gen Sequencing (NGS)-based multi-gene panels
S.no | Sample Requirement | Sample Requirement |
Disease-specific testing of sequencing of multiple genes -
| 4 ml Peripheral blood (EDTA) |